Multidisciplinary Approach to Fatigue
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-39
SponsorJules Bordet Institute
About this trial
Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour
Eligibility criteria
Qualifiers
Age between 18 and 39 years at the time of signing the informed consent
Patient who speaks and understands French
Signed study informed consent form obtained prior to any study related procedures
At minimum, a moderate (>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program
Disqualifiers
Refusal to participate in the study
Patient having chosen to participate in another psychosocial intervention study for the duration of the study.
Patients with AJCC stage IV breast cancer
Trial design
Treatments tested in this trial
- Ergospirometry
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov